Corrigendum to "BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells"[Immunology Letters 230 (2021) 27-35].
Immunol Lett
; 253: 54-55, 2023 Jan.
Article
en En
| MEDLINE
| ID: mdl-36572610
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Immunol Lett
Año:
2023
Tipo del documento:
Article